MHRA approves the Moderna COVID-19 vaccine ‘Spikevax’ for use in 6 to 11-year olds
News story Use of the Moderna COVID-19 vaccine or ‘Spikevax’ has been approved for 6 to 11s after meeting the required safety, quality and effectiveness standards The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an… read more

